You are here
Press Releases
2017
The CEO Roundtable on Cancer has accredited Pappas Capital, in Durham, NC, with CEO Cancer Gold StandardTM accreditation, recognizing its efforts to reduce the risk of cancer for its employees and covered family members.
The CEO Roundtable on Cancer honored the U.S. Food and Drug Administration (FDA) with the 2017 Dr. Charles A. Sanders Life Sciences Award in recognition of their continued and expanded collaboration with the CEO Roundtable on Cancer’s Life Sciences Consortium and Project Data Sphere, LLC.
Through a grant from the Robert Wood Johnson Foundation (RWJF), outreach efforts are underway to encourage academic institutions to adopt the CEO Cancer Gold Standard, a no cost employer-led health and wellness initiative that recognizes exceptional workplaces committed to reducing the burden of cancer for their employees.
The CEO Roundtable on Cancer has accredited Cree in Durham, NC with the CEO Cancer Gold StandardTM recognizing its efforts to reduce the risk of cancer for its employees and covered family members.
CARY, NC (May 30, 2017) – The University of North Dakota has earned CEO Cancer Gold Standard™ re-accreditation for maintaining a strong commitment to the health of its employees and satisfying the comprehensive requirements of the Gold Standard for the past ten years.
CARY, N.C. (04/03/2017) The CEO Roundtable on Cancer has accredited LEERINK Partners LLC in Boston, MA with the CEO Cancer Gold StandardTM recognizing its efforts to reduce the risk of cancer for its employees and covered family members.
The CEO Roundtable on Cancer has accredited CVS Health (NYSE: CVS), the nation’s largest pharmacy innovation company, with the CEO Cancer Gold Standard, recognizing its efforts to reduce the risk of cancer for its employees and covered family members. The company earned the distinguished Gold Standard accreditation for taking actions in five key areas of health and wellness to fight cancer in the workplace, including: discouraging tobacco use; encouraging physical activity; promoting healthy diet and nutrition; detecting cancer at its earliest stages; and providing access to quality care.
2016
The CEO Roundtable on Cancer has elected Joaquin Duato of Johnson & Johnson to its Board of Directors.
The CEO Roundtable on Cancer presented the Robert Wood Johnson Foundation with the 2016 Dr. Charles A. Sanders Life Sciences Award in recognition of their innovative and collaborative work in the CEO Roundtable on Cancer’s Life Sciences Consortium.
The CEO Roundtable on Cancer has accredited Focused Ultrasound Foundation in Charlottesville, VA, with the CEO Cancer Gold StandardTM, recognizing its efforts to reduce the risk of cancer for its employees and covered family members.
The CEO Roundtable on Cancer has accredited 3M Austin Center in Austin, TX with the CEO Cancer Gold Standard™ recognizing its efforts to reduce the risk of cancer for its employees and covered family members.
The CEO Cancer Gold Standard, the employer health and wellness accreditation program of the CEO Roundtable on Cancer, is now helping more than 5 million employees and their family members prevent and address cancer through workplace-based programming as the first six Gold Standard employers celebrate ten years of accreditation.
The CEO Roundtable on Cancer has accredited Hatteras Venture Partners, an early-stage venture capital investment company in Durham, N.C., with the CEO Cancer Gold StandardTM recognizing its efforts to reduce the risk of cancer for its employees and covered family members.
The CEO Roundtable on Cancer has accredited The Ohio State University in Columbus, Ohio, with the CEO Cancer Gold Standard™, recognizing its efforts to reduce the risk of cancer for its employees and covered family members.
2015
The CEO Roundtable on Cancer presented the Alliance for Clinical Trials in Oncology and Pfizer with the 2015 Dr. Charles A. Sanders Life Sciences Awards.